Macher Jean Paul (2009): Dialogues in Clinical Neuro Science, 2009 Editorial, Volume 11, No. 4, pp. 357.
Patkar S.V. (2013): Add grace to psychiatric practice, Indian J. Psychiatry. 2013, Vol. 55, No. 2 pp. 197–199.
Downing J Gregory (2009): Policy perspectives on emerging pathways of personalized medicine: Dialogues in Clinical Neurosciences pp 379
Evers Kathinka (2009): Clinical research, Dialogues in Clinical Neurosciences PP. 432.
Essali A. Al Haj H. N. et al (2002): Clonazipine versus Typical Neuroleptic Medication for Schizophrenia (review). Cochrane Database Syst. Rev. 2002: D000059.
Nose M., Barbul C, Tanselta M (2002) How often do patients with psychosis fail to adhere to treatment programmes?Asystematic review, Pshycho Med. 2003;33 1149-1160.
de Leon J. (2009): Pharmacogenomics: the promise of personalized medicine for CNS disorder. Neuro Psychopharmacology, 2009, 34: 159–172.
Cuijpers Pim (2009): Prevention: an achievable goal in personalized medicine: Dialogues in Clinical Neurosciences; 2009, Volume 11, No. 4 pp, 447–454.
Drake Robert E; Cimpeon Delia; and Torrey William (2009): Shared decision making in mental health: prospects for personalized medicine. Dialogues in Clincal Neurosciences; 2009, Volume 11, No. 4, pp 455–463.
